[Infection-associated Acute Posterior Multifocal Placoid Pigment Epitheliopathy]

F Jordan1, U Voigt1, J Dawczynski2

  • 1Klinik für Augenheilkunde, Universitätsklinikum Jena.

Klinische Monatsblatter Fur Augenheilkunde
|April 5, 2017
PubMed

Insights

Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a rare inflammatory eye condition affecting young adults. While often self-limiting with good prognosis, prompt diagnosis and monitoring are key for visual health.

Area of Science:

  • Ophthalmology
  • Inflammatory Chorioretinopathy

Background:

  • Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a rare inflammatory chorioretinopathy.
  • It predominantly affects young, light-skinned, myopic adults aged 20-30.
  • The precise etiology remains unknown, though preceding viral or flu-like illnesses are sometimes reported.

Purpose of the Study:

  • To present a case example of APMPPE.
  • To demonstrate the typical symptoms, diagnostic work-up, and available treatment options for APMPPE.
  • To highlight the importance of monitoring in managing this condition.

Main Methods:

  • Case report presentation.
  • Review of diagnostic imaging and clinical findings.
  • Discussion of management strategies based on current literature and clinical experience.

Main Results:

  • APMPPE typically presents with sudden, usually temporary, visual loss.
  • The condition is generally bilateral and self-limiting, with a good prognosis.
  • Foveal involvement can negatively impact the visual prognosis.

Conclusions:

  • There is no established consensus on APMPPE treatment.
  • A conservative 'wait-and-see' approach with frequent monitoring is often sufficient.
  • Early recognition and management are crucial for optimizing visual outcomes in APMPPE patients.